Skip to content

Clinical study of Dachaihu decoction in promoting gastrointestinal function recovery after gastrointestinal tumor surgery

Clinical study of Dachaihu decoction in promoting gastrointestinal function recovery after gastrointestinal tumor surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005722
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumors

Interventions

test group:On the basis of conventional treatment, Dachaihu was added
control group:Conventional treatment

Sponsors

Shanxi Provincial Hospital of Traditional Chinese Medicine (Shanxi Provincial Institute of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria for gastric cancer and colorectal cancer and require radical surgery; (2) The age is between 18-80 years old, and the gender is not limited; (3) No history of abdominal surgery; (4) Informed consent, volunteer subjects.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women; (2) Patients with severe primary cardiovascular and cerebrovascular disease, liver disease, kidney disease, hematological disease, lung disease, or serious diseases that affect their survival, such as tumors; (3) History of severe gastrointestinal disease; (4) Patients with mental disorders; (5) Those who did not take the prescribed medication, or interrupted the treatment, had serious postoperative complications and could not determine the curative effect.

Design outcomes

Primary

MeasureTime frame
The number of postoperative complications and the number of adverse reactions after taking the drug;Number and degree of abdominal pain and abdominal distension at 1, 3, and 7 days after operation;Gastrointestinal function recovery effect;Post-operative days of hospitalization and hospitalization expenses;Postoperative bowel sounds recovery and time to first exhaust and defecation;Changes in blood routine, C-reactive protein (CRP), vasoactive intestinal peptide (VIP), motilin (MOT), and somatostatin (SS) levels on the 1st, 3rd, and 7th days after operation;

Countries

China

Contacts

Public ContactZhang Youfu
zhyf34502@sina.com13835188052

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026